Financial statements Heron 2
Balance sheet data of HERON 2
|
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 27 147 991,19 | 31 823 383,49 | 42 604 627,50 | 40 044 881,17 | 39 781 160,46 | 62 343 198,82 |
| A. Fixed assets | 25 340 190,55 | 29 194 833,26 | 38 119 893,48 | 38 335 371,07 | 38 419 508,39 | 59 195 739,60 |
| B. Current assets | 1 807 800,64 | 2 628 550,23 | 4 484 734,02 | 1 709 510,10 | 1 361 652,07 | 3 147 459,22 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 27 147 991,19 | 31 823 383,49 | 42 604 627,50 | 40 044 881,17 | 39 781 160,46 | 62 343 198,82 |
| A. Equity | -50 599,15 | 5 888 911,98 | 18 664 468,60 | 29 229 304,34 | 29 388 772,02 | 31 620 988,02 |
| B. Liabilities and provisions for liabilities | 27 198 590,34 | 25 934 471,51 | 23 940 158,90 | 10 815 576,83 | 10 392 388,44 | 30 722 210,80 |
| I. Long-term liabilities | 21 556 993,08 | 9 430 000,00 | 8 650 000,00 | 7 750 000,00 | 6 730 000,00 | 24 193 622,92 |
| II. Short-term liabilities | 3 640 477,26 | 16 502 671,51 | 15 290 158,90 | 3 065 576,83 | 3 662 388,44 | 6 528 587,88 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.